Streptococcus gallolyticus - A potentially neglected pathogen causing neonatal sepsis not covered by routine group B streptococcus screening

J Microbiol Immunol Infect. 2021 Dec;54(6):1190-1192. doi: 10.1016/j.jmii.2021.05.003. Epub 2021 May 15.

Abstract

We report 4 cases of neonatal sepsis caused by Streptococcus gallolyticus. The clinical course was quite similar to early-and late-onset group B streptococcus disease. None of the mothers had group B streptococcus (GBS) colonization on prenatal screening nor received intrapartum antibiotics. We proposed the sporadic distribution of S. gallolyticus sepsis among neonates was partly due to relatively low colonization rate in adults compared with GBS. Species determination of S. gallolyticus may not be available using conventional microbiological methods and may contribute to underestimation or misclassification. In our series, we highlighted the importance of S. gallolyticus as an important pathogen in neonatal sepsis deserving further surveillance.

Keywords: Neonatal sepsis; Streptococcus gallolyticus.

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Neonatal Sepsis / diagnosis
  • Neonatal Sepsis / drug therapy
  • Neonatal Sepsis / microbiology*
  • Streptococcal Infections / diagnosis
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / microbiology*
  • Streptococcus agalactiae / isolation & purification
  • Streptococcus gallolyticus / drug effects
  • Streptococcus gallolyticus / isolation & purification*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents